Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00785733
Other study ID # NIS-RRO-SYM-2008/1
Secondary ID
Status Completed
Phase N/A
First received November 4, 2008
Last updated November 30, 2010
Start date November 2008
Est. completion date October 2009

Study information

Verified date November 2010
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Romania: National Medicines Agency
Study type Observational

Clinical Trial Summary

The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period


Recruitment information / eligibility

Status Completed
Enrollment 1182
Est. completion date October 2009
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients eligible for entry into study are the patients diagnosed with moderate to severe asthma, that the doctors have already decided to treat with Symbicort SMART within the last month, before inclusion in this program

- All eligible patients will be included in the protocol provided they will receive detailed information in advance and will sign consent to grant access to their own data collected during this programme.

Exclusion Criteria:

- All the patients who have a known hypersensitivity to Symbicort or any of its excipients will not be included in this study.

- As per valid Romanian SmPC, concomitant medication, that could result in drug interactions and could jeopardise patient safety will be carefully considered before having the patient enrolled.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Romania Research Site Alba Iulia
Romania Research Site Alexandria
Romania Research Site Arad
Romania Research Site Bacau
Romania Research Site Baia Mare
Romania Research Site Botosani
Romania Research Site Braila
Romania Research Site Brasov
Romania Research Site Breaza
Romania Research Site Bucuresti
Romania Research Site Buftea
Romania Research Site Calarasi
Romania Research Site Campina
Romania Research Site Campulung
Romania Research Site Cluj Napoca
Romania Research Site Constanta
Romania Research Site Craiova
Romania Research Site Deva
Romania Research Site Drobeta Turnu Severin
Romania Research Site Giurgiu
Romania Research Site Hunedoara
Romania Research Site Iasi
Romania Research Site Leordeni
Romania Research Site Miercurea Ciuc
Romania Research Site Mizil
Romania Research Site Oradea
Romania Research Site Palazu Mare
Romania Research Site Piatra Neamt
Romania Research Site Pitesti
Romania Research Site Ploiesti
Romania Research Site Resita
Romania Research Site Rm. Valcea
Romania Research Site Scornicesti
Romania Research Site Sf. Gheorghe
Romania Research Site Sibiu
Romania Research Site Slobozia
Romania Research Site Suceava
Romania Research Site Targoviste
Romania Research Site Targu Mures
Romania Research Site Tg. Jiu
Romania Research Site Timisoara
Romania Research Site Tulcea
Romania Research Site Vaslui
Romania Research Site Zalau

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Romania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asthma Control Questionnaire ACQ 5 visits (V1-week 0, V2-week 4, V3-week 8, V4-week 16, V5-week 24) No